Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/87498
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJackowski, L.-
dc.contributor.authorWorthley, D.-
dc.contributor.authorPhillips, P.-
dc.date.issued2012-
dc.identifier.citationMedicine Today: the peer reviewed journal of clinical practice, 2012; 13(1):44-47-
dc.identifier.issn1443-430X-
dc.identifier.urihttp://hdl.handle.net/2440/87498-
dc.description.abstractThere is strong evidence supporting the use of low-dose aspirin in the secondary prevention of cardiovascular events in patients with type, diabetes but the evidence is less robust in primary prevention. Also, aspirin use can be associated with serious gastrointestinal haemorrhage.-
dc.description.statementofresponsibilityLeslie Jackowski, Dan Worthley, Pat Phillips-
dc.language.isoen-
dc.publisherMedicine Today-
dc.rightsMedicine Today Pty Ltd-
dc.titleCardioprotective aspirin in type 2 diabetes-
dc.typeJournal article-
pubs.publication-statusPublished-
dc.identifier.orcidWorthley, D. [0000-0003-0374-9124]-
Appears in Collections:Aurora harvest 7
General Practice publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.